Position
ALGERT GLOBAL LLC in Vaxcyte, Inc.
Back to the book · All holders of PCVX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $807$0.05 → $0.06
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 67.4K | $3.11K | — | — | — | 0.0% |
| Q1 2026 | 364K | $21.2K | $0.06 | $807 | $17.2K | 0.3% |